Phase III multicenter, randomized, controlled trial to determine the efficacy and safety of two dose levels of Plitidepsin compared to control in adult patients requiring hospitalization for medical treatment of
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: PHARMA MAR, SA
- Phase: III
- Execution start: 25/08/2021
- End of execution: 30/09/2021
- IP: JOSE HERNANDEZ QUERO